Valsts: Amerikas Savienotās Valstis
Valoda: angļu
Klimata pārmaiņas: NLM (National Library of Medicine)
GOLDENSEAL (UNII: ZW3Z11D0JV) (GOLDENSEAL - UNII:ZW3Z11D0JV)
Paramesh Banerji Life Sciences LLC
ORAL
OTC DRUG
Liver ailments Liver ailments
unapproved homeopathic
HYDRASTIS CANADENSIS 200C- HYDRASTIS CANADENSIS PELLET PARAMESH BANERJI LIFE SCIENCES LLC _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- DRUG FACTS: ACTIVE INGREDIENT Hydrastis canadensis 200C HPUS INACTIVE INGREDIENTS Sucrose, Lactose PURPOS E Liver ailments US ES Liver ailments WARNINGS If pregnant or breast feeding ask a health professional before use. KEEP OUT OF REACH OF CHILDREN Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. DIRECTION Adult or child: Take three pills daily. Leaving a gap of 30 minutes after any food or as advised by your physician. MANUFACTURED BY Paramesh Banerji Life Sciences, LLC. North Brunswick, NJ 08902, USA. Tel: +1-732-743-5936, Email: info@pblifesciences.com www.pblifesciences.com/permapotent PRINCIPAL DISPLAY PANEL NDC: 69152-1102-1 Hydrastis canadensis 200C Homeopathic Medicine Liver ailments 96 Pills (Approx.) Product of USA HYDRASTIS CANADENSIS 200C hydrastis canadensis pellet PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:6 9 152-110 2 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH GO LDENSEAL (UNII: ZW3Z11D0 JV) (GOLDENSEAL - UNII:ZW3Z11D0 JV) GOLDENSEAL 20 0 [hp_C] Paramesh Banerji Life Sciences LLC INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SUCRO SE (UNII: C151H8 M554) LACTO SE (UNII: J2B2A4N9 8 G) PRODUCT CHARACTERISTICS COLOR white S CORE S HAP E ROUND S IZ E 4mm FLAVOR IMPRINT CODE CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 9 152-110 2-1 9 6 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct 0 6 /22/20 15 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved ho meo pathic 0 6 /22/20 15 LABELER - Izlasiet visu dokumentu